Remimazolam attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis involving the AKT/SLC7A11/GPX4 axis.

Chen X, Zhao J, He X, Zhang Y, Wu J, Jiang C, Yang Y, Xiao J

Open source

DOI
10.3892/ijmm.2026.5998
Published
2026 Nov
Container
International journal of molecular medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/ijmm.2026.5998,
  title = {Remimazolam attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis involving the AKT/SLC7A11/GPX4 axis.},
  author = {Chen X and Zhao J and He X and Zhang Y and Wu J and Jiang C and Yang Y and Xiao J},
  year = {2026},
  journal = {International journal of molecular medicine},
  doi = {10.3892/ijmm.2026.5998},
  url = {https://doi.org/10.3892/ijmm.2026.5998}
}

RIS

TY  - JOUR
TI  - Remimazolam attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis involving the AKT/SLC7A11/GPX4 axis.
AU  - Chen X
AU  - Zhao J
AU  - He X
AU  - Zhang Y
AU  - Wu J
AU  - Jiang C
AU  - Yang Y
AU  - Xiao J
PY  - 2026
JO  - International journal of molecular medicine
DO  - 10.3892/ijmm.2026.5998
UR  - https://doi.org/10.3892/ijmm.2026.5998
ER  - 

APA

X, C., J, Z., X, H., Y, Z., J, W., C, J., Y, Y., & J, X. (2026). Remimazolam attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis involving the AKT/SLC7A11/GPX4 axis.. International journal of molecular medicine. https://doi.org/10.3892/ijmm.2026.5998

Source records